What area percent purity actually measures
The main peak area divided by the total area of all peaks, expressed as a percentage. That is the whole calculation, and it is a statement about the chromatogram rather than about the vial.
It answers one question: of the material that eluted from this column and absorbed at this wavelength, what fraction was the main component. Everything the method could not see, salts, water, solvent, anything that did not elute or did not absorb, is absent from both the numerator and the denominator.
The equal response assumption
Converting area into amount assumes every species absorbs equally per unit mass at the detection wavelength. That is a convenient approximation and it is not true. At 214 nm the peptide bond dominates, so response scales roughly with chain length and the approximation is fair. At 280 nm it depends entirely on aromatic content, and an impurity with no tryptophan or tyrosine is invisible.
This is why 214 nm is the usual wavelength for a purity determination and 280 nm for a concentration measurement.
What impurity peaks are, by where they elute
Reverse-phase retention tracks hydrophobicity, so anything that makes a peptide more polar pulls it earlier and anything that makes it less polar pushes it later. That relationship turns retention time into a hypothesis about the impurity.
Oxidised methionine and deamidated asparagine are both more polar than the parent and both elute earlier. Deletion sequences, missing one residue, are usually shorter and more polar and also elute earlier. Incompletely deprotected peptides carry a hydrophobic protecting group and elute later, as do dimers and aggregates.
- •Well before the main peak: salt front, truncated fragment or scavenger residue
- •Slightly before: oxidation, deamidation or a deletion sequence
- •Shoulder on the main peak: a diastereomer or a very closely related variant
- •Slightly after: epimerised residue or a closely related sequence variant
- •Well after: incompletely deprotected peptide, dimer or hydrophobic impurity
The direction this tool used to get wrong
The classification here previously offered oxidation and deamidation as explanations for peaks eluting after the main one. Both modifications make a peptide more polar, so both elute before it on a reverse-phase column.
The classification now runs the correct way round. It remains a hypothesis to test rather than an identification: confirming what a peak is means collecting it and running mass spectrometry on it.
What a purity figure cannot tell you
It cannot tell you that the main peak is the right molecule. A 99 percent pure preparation of the wrong peptide is 99 percent pure. Identity is a mass spectrometry question, and a certificate reporting purity without a mass is reporting half the answer.
It also says nothing about how much peptide is in the vial. Purity is a ratio among the things that eluted; net peptide content is an absolute figure that also accounts for counterions and water. A vial can be 99 percent pure and still be only 80 percent peptide by weight.
How purity is calculated from peak areas
One division, plus a retention-time heuristic that classifies each impurity peak by where it eluted relative to the main one.
total area = main peak area + SUM(impurity areas) purity % = main peak area / total area x 100 largest imp% = largest impurity area / total area x 100 relative RT = (impurity RT - main RT) / main RT
- Sum all the peak areas. Main peak plus every impurity you enter. Peaks omitted from the entry are omitted from the denominator, which raises the reported purity.
- Divide and express as a percentage. The main peak's share of the total. This is area percent purity, the figure a certificate quotes.
- Identify the largest single impurity. Regulatory thinking treats a single large impurity differently from the same total spread across many small ones, so the largest is reported separately.
- Compute relative retention for each impurity. The difference from the main peak divided by the main peak's retention time, which makes the classification independent of the absolute run length.
- Classify by direction and distance. Earlier means more polar, later means more hydrophobic, and the distance separates a close variant from a distant one. The result is a hypothesis, not an identification.
What this method cannot tell you
- •It assumes equal detector response per unit mass across all species, which is a working approximation at 214 nm and a poor one at 280 nm.
- •It only counts peaks you enter. Anything that co-elutes, does not elute or does not absorb is missing from the calculation entirely.
- •It says nothing about identity. Purity and identity are separate questions and need separate methods.
- •The impurity classification is a heuristic based on retention direction. Confirming what a peak is requires collecting it and analysing it.
HPLC purity interpreter: frequently asked questions
The main peak area divided by the total area of all peaks, times 100. It is called area percent purity.
A main peak of 9,900 area units against impurities totalling 100 gives 99 percent.
No, and this is the most consequential misreading of a certificate. Purity is a ratio among the species that eluted and absorbed at the detection wavelength.
Counterions, water and residual solvent are invisible to the chromatogram. A vial can be 99 percent pure by HPLC and only 80 percent peptide by weight. The net peptide content calculator works the difference through.
214 nm, where the peptide bond absorbs, so every peptide-related species is detected in rough proportion to its length.
At 280 nm only tryptophan and tyrosine absorb, so any impurity lacking them is invisible and the purity figure is inflated. A certificate that reports purity at 280 nm is reporting a weaker number than it appears to.
It depends on length and on what the material is for.
- •Above 99 percent: high grade, appropriate for sensitive quantitative work
- •95 to 99 percent: the range most research-grade material falls in
- •90 to 95 percent: acceptable for some purposes, worth asking what the impurities are
- •Below 90 percent: unusual for a purified peptide and worth investigating
Longer peptides are harder to purify, so a 40 residue peptide at 95 percent represents more work than a 10 residue one at 98.
That it is more polar than the parent peptide, since reverse-phase retention tracks hydrophobicity.
Oxidation, deamidation and deletion sequences all make a peptide more polar and all elute earlier. A peak well before the main one is more likely a salt front, a truncated fragment or a scavenger residue.
That it is more hydrophobic. Incompletely deprotected peptides carrying a protecting group, acylated variants, and dimers or aggregates all elute later.
A very strongly retained late peak often indicates aggregation rather than a covalent impurity.
Because it had the direction backwards for the most common case. Oxidation and deamidation were offered as explanations for late-eluting peaks.
Both modifications add polarity, so both elute earlier than the parent. The classification now runs the correct way round.
A chain missing one or more residues, produced when a coupling step during solid-phase synthesis does not go to completion.
They are the most common synthesis-related impurity, and they are usually shorter and more polar than the target, so they elute earlier.
C18 is the standard choice for most peptides. C8 and C4 retain less and are used for larger or more hydrophobic molecules that C18 holds too tightly.
The stationary phase determines the selectivity, so two certificates from different columns are not directly comparable even at the same nominal purity.
Yes, and that is the failure mode a purity figure cannot detect. A co-eluting impurity is counted inside the main peak and inflates the result.
Peak shape is the clue: a shoulder, a tail or an asymmetric peak suggests something hidden underneath. An orthogonal method, a different column chemistry or a different mobile phase, is what resolves it.
Because two percent as one peak and two percent spread across ten peaks are different situations. A single large impurity is one identifiable species present in quantity.
Regulatory frameworks for pharmaceutical impurities treat them differently for the same reason.
Yes, along with salt content and water. A 10 mg vial at 95 percent purity as an acetate salt contains roughly 8.6 mg of peptide.
The purity calculator and the net peptide content calculator apply the corrections in sequence.
A programmed increase in organic solvent over the run, which elutes progressively more hydrophobic species.
Retention time depends on the gradient, so two chromatograms of the same peptide under different gradients give different times. This is why relative retention, rather than absolute, is the comparable quantity.
Yes. A purity number alone hides peak shape, baseline quality and whether the gradient was long enough to elute late-running species.
A clean baseline and a symmetric main peak say things a percentage cannot. The COA red flag checker lists what else to look for.
Only by comparison against a reference standard run on the same method, and even then retention time is weak evidence.
Identity is a mass spectrometry question. A certificate reporting purity without a mass spectrum is answering half of it.
A closely related species that the method has not fully resolved: often a diastereomer, an epimer at one residue, or a modification that barely changes hydrophobicity.
Shoulders are partly counted in the main peak area, so a chromatogram with a shoulder reports a purity higher than the true figure.
Related Products
Related Research News
Why 99% Purity Means Something Different on a Tripeptide and a 44-mer
At 99% per coupling a tripeptide comes off the resin 98% correct and a 44-residue chain comes off at 65%. What had to be removed, why deletion sequences are the hardest impurity to separate, and the trifluoroacetate counterion that is in the vial and not on the paperwork.
What a Peptide Blend Costs You Analytically
Put four peptides in one vial and ask what its purity figure refers to. The largest peak is not the product, and the other three peaks are not impurities. What a blend costs you analytically, with our own four blends audited against the same standard.
Zepbound in Peptide Research: Sleep, Mood, and Metabolic Context
Zepbound is a brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist. This guide explains where it fits in peptide research, why sleep and mood peptides like DSIP, Selank, and Epitalon matter for metabolic studies, and how to verify compound identity, purity, and stability before any preclinical work. It also maps the Volta tools and research pages that support that validation.